{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:20:49Z","timestamp":1784042449727,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006442","name":"Det Sundhedsvidenskabelige Fakultet, K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.neuropharm.2019.06.002","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T02:37:53Z","timestamp":1559615873000},"page":"107663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["G protein-coupled receptor signaling in VTA dopaminergic neurons bidirectionally regulates the acute locomotor response to amphetamine but does not affect behavioral sensitization"],"prefix":"10.1016","volume":"161","author":[{"given":"Annika H.","family":"Runegaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditte","family":"Dencker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitta","family":"W\u00f6rtwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik","family":"Gether","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.06.002_bib1","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1073\/pnas.0700293104","article-title":"Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand","volume":"104","author":"Armbruster","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/jnc.12197","article-title":"Amphetamine augments vesicular dopamine release in the dorsal and ventral striatum through different mechanisms","volume":"125","author":"Avelar","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1124\/mol.108.048447","article-title":"Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux","volume":"74","author":"Binda","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00018-008-8552-x","article-title":"Rac 1 GTPase: a \u201cRac\u201d of all trades","volume":"66","author":"Bosco","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/01677063.2014.908191","article-title":"The dopamine transporter expression level differentially affects responses to cocaine and amphetamine","volume":"28","author":"Cagniard","year":"2014","journal-title":"J. Neurogenet."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib6","doi-asserted-by":"crossref","first-page":"8923","DOI":"10.1523\/JNEUROSCI.1033-13.2013","article-title":"Amphetamine mechanisms and actions at the dopamine terminal revisited","volume":"33","author":"Calipari","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib7","series-title":"Amphetamine Self-Administration Attenuates Dopamine D2 Autoreceptor Function","first-page":"1","author":"Calipari","year":"2014"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib8","doi-asserted-by":"crossref","first-page":"19066","DOI":"10.1074\/jbc.M117.787002","article-title":"Dopamine transporter phosphorylation site threonine 53 is stimulated by amphetamines and regulates dopamine transport, efflux, and cocaine analog binding","volume":"292","author":"Challasivakanaka","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib9","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1124\/jpet.108.147959","article-title":"Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice","volume":"328","author":"Chen","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1523\/JNEUROSCI.2136-12.2013","article-title":"Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals","volume":"33","author":"Daberkow","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib11","article-title":"Cocaine engages a non-canonical, dopamine-independent, mechanism that controls neuronal excitability in the nucleus accumbens","author":"Delint-Ramirez","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.neuron.2006.06.028","article-title":"Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport","volume":"51","author":"Fog","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","article-title":"The role of D2-autoreceptors in regulating dopamine neuron activity and transmission","volume":"282","author":"Ford","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib14","doi-asserted-by":"crossref","first-page":"10652","DOI":"10.1038\/ncomms10652","article-title":"Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain","volume":"7","author":"Freyberg","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0165-6147(93)90029-J","article-title":"Molecular characterization of the dopamine transporter","volume":"14","author":"Giros","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib16","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.aan2475","article-title":"Chemogenetics revealed: DREADD occupancy and activation via converted clozapine","volume":"357","author":"Gomez","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib18","doi-asserted-by":"crossref","first-page":"19197","DOI":"10.1073\/pnas.0906593106","article-title":"A chemical-genetic approach to study G protein regulation of beta cell function in vivo","volume":"106","author":"Guettier","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib19","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nchembio.1545","article-title":"PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein","volume":"10","author":"Hamilton","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib20","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1074\/jbc.M413887200","article-title":"Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta","volume":"280","author":"Johnson","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib21","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1371\/journal.pbio.0020078","article-title":"N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux","volume":"2","author":"Khoshbouei","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.tiv.2007.01.009","article-title":"Inhibition by cocaine of G protein-activated inwardly rectifying K+ channels expressed in Xenopus oocytes","volume":"21","author":"Kobayashi","year":"2007","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: structure, function, and regulation","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.neuron.2011.01.017","article-title":"Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling","volume":"69","author":"Luscher","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib25","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0219-16.2016","article-title":"Clozapine N-oxide administration produces behavioral effects in long-evans rats: implications for designing DREADD experiments","volume":"3","author":"MacLaren","year":"2016","journal-title":"eNeuro"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1471-4159.2003.01784.x","article-title":"Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats","volume":"86","author":"Narita","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.neuron.2011.12.031","article-title":"Methamphetamine-evoked depression of GABA(B) receptor signaling in GABA neurons of the VTA","volume":"73","author":"Padgett","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/mp.2013.29","article-title":"Amphetamine-induced behavior requires CaMKII-dependent dopamine transporter phosphorylation","volume":"19","author":"Pizzo","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib29","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1471-4159.2011.07407.x","article-title":"High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat","volume":"119","author":"Ramsson","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib30","doi-asserted-by":"crossref","first-page":"27534","DOI":"10.1074\/jbc.M112.441295","article-title":"Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release","volume":"288","author":"Rickhag","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.neuron.2016.01.040","article-title":"DREADDs for neuroscientists","volume":"89","author":"Roth","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib32","first-page":"34","article-title":"Modulating dopamine signaling and behavior with chemogenetics: concepts, progress and challenges","volume":"72","author":"Runegaard","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/ejn.13347","article-title":"Preserved dopaminergic homeostasis and dopamine-related behaviour in hemizygous TH-Cre mice","volume":"45","author":"Runegaard","year":"2017","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2019.06.002_bib34","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0345-17.2018","article-title":"Locomotor- and reward-enhancing effects of cocaine are differentially regulated by chemogenetic stimulation of gi-signaling in dopaminergic neurons","volume":"5","author":"Runegaard","year":"2018","journal-title":"Eneuro"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib35","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1523\/JNEUROSCI.0760-05.2005","article-title":"Bcl-x is required for proper development of the mouse substantia nigra","volume":"25","author":"Savitt","year":"2005","journal-title":"J. Neurosci. : The Off. J. Soc. Neurosci"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib36","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1523\/JNEUROSCI.0760-05.2005","article-title":"Bcl-x is required for proper development of the mouse substantia nigra","volume":"25","author":"Savitt","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib37","article-title":"Methamphetamine self-administration in mice decreases GIRK channel-mediated currents in midbrain dopamine neurons","volume":"18","author":"Sharpe","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib38","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1523\/JNEUROSCI.4050-13.2014","article-title":"Biphasic mechanisms of amphetamine action at the dopamine terminal","volume":"34","author":"Siciliano","year":"2014","journal-title":"J. Neurosci. : The Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib39","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1471-4159.1998.71031289.x","article-title":"Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter","volume":"71","author":"Sitte","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/pr.109.001933","article-title":"Drug wanting: behavioral sensitization and relapse to drug-seeking behavior","volume":"63","author":"Steketee","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib41","doi-asserted-by":"crossref","first-page":"10924","DOI":"10.1074\/jbc.M109.083154","article-title":"The N terminus of monoamine transporters is a lever required for the action of amphetamines","volume":"285","author":"Sucic","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib42","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1523\/JNEUROSCI.15-05-04102.1995","article-title":"Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport","volume":"15","author":"Sulzer","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib43","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: a review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0022-3565(24)38104-2","article-title":"Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine","volume":"289","author":"Tolliver","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.06.002_bib45","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuron.2014.05.043","article-title":"Amphetamine modulates excitatory neurotransmission through endocytosis of the glutamate transporter EAAT3 in dopamine neurons","volume":"83","author":"Underhill","year":"2014","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neuropharm.2019.06.002_bib46","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12264-013-1327-x","article-title":"Pharmacogenetic activation of midbrain dopamine neurons produces hyperactivity","author":"Wang","year":"2013","journal-title":"Neuroscience bulletin"},{"key":"10.1016\/j.neuropharm.2019.06.002_bib47","first-page":"1","article-title":"Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine","author":"Wheeler","year":"2015","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2019.06.002_bib48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuropharm.2004.07.010","article-title":"Rapid regulation of the dopamine transporter: role in stimulant addiction?","volume":"47","author":"Zahniser","year":"2004","journal-title":"Neuropharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819302096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819302096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:57:40Z","timestamp":1758437860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819302096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":48,"alternative-id":["S0028390819302096"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.06.002","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"G protein-coupled receptor signaling in VTA dopaminergic neurons bidirectionally regulates the acute locomotor response to amphetamine but does not affect behavioral sensitization","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107663"}}